Three-Year Interval Feasible for Stool-Based CRC Screening in Low-Risk People
TUESDAY, Dec. 6, 2022 (HealthDay News) -- A three-year interval for multitarget stool DNA (mt-sDNA) colorectal cancer (CRC) screening for those at average risk appears clinically appropriate, according to a study published online Oct. 7 in Cancer Prevention Research. Thomas F. Imperiale, M.D., from the Indiana University School of Medicine in Indianapolis, and colleagues examined
Source: physiciansweekly.com